ArticleThe oncologist2025
Prevalence and impact of frailty on unplanned hospitalizations among adult patients with cancer in Taiwan.
Article in The oncologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High burden of geriatric assessment impairments across the adult age spectrum in patients with cancer.The oncologist · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionFrailty is common among older patients with cancer and may influence treatment outcomes. This study evaluated frailty prevalence and its association with unplanned hospitalizations in adult cancer patients. MATERIALS AND
methodsWe prospectively included 2081 patients with newly diagnosed cancer from 3 medical centers in Taiwan (2018-2022) who were scheduled to undergo cancer treatment. Frailty was assessed using a comprehensive geriatric assessment within 7 days before treatment initiation. Patients were categorized as fit, pre-frail, or frail to assess the impact on 90-day unplanned hospitalization.
resultsThe prevalence of fit, pre-frail, and frail patients was 16.7%, 32.2%, and 51.0%, respectively. Frailty was associated with older age, unmarried status, lower education, unemployment, poor ECOG performance status, cancer site, and advanced stage (all P < .001). Core contributors to frailty across cancer sites included malnutrition, comorbidity, and polypharmacy. Functional impairment was prominent in patients with gastrointestinal, hematologic, and genitourinary cancers, while cognitive impairment was notable in those with genitourinary cancers. Unplanned hospitalization rates were highest in the frail group (41.5%), followed by pre-frail (34.4%) and fit (25.9%) patients. Frailty remained independently associated with unplanned hospitalizations after adjustment: pre-frail (adjusted odds ratio [OR] 1.44; 95% CI 1.06-1.94; P = .018) and frail (OR 2.07; 95% CI 1.55-2.76; P < .001).
conclusionFrailty was prevalent and significantly associated with increased risk of unplanned hospitalization. These findings support the integration of frailty screening in routine oncology care to guide clinical decisions for vulnerable cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.